<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药融投资 | wechat-feeds</title><link>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 05 Feb 2021 16:54:50 +0800</pubDate><image><url>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</url><title>药融投资 | wechat-feeds</title><link>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>新春预告：大湾区(广州)生物医药创新者峰会启动</title><link>https://mp.weixin.qq.com/s/GI5Pu97uuncrKaGQyEtWtA</link><description></description><content:encoded><![CDATA[新春预告：大湾区(广州)生物医药创新者峰会启动]]></content:encoded><pubDate>Fri, 05 Feb 2021 13:48:51 +0800</pubDate></item><item><title>酶催化特色药企：弈柯莱生物辅导上市中</title><link>https://mp.weixin.qq.com/s/EReK7fQsRWWVp6t5oDGc4g</link><description></description><content:encoded><![CDATA[酶催化特色药企：弈柯莱生物辅导上市中]]></content:encoded><pubDate>Thu, 28 Jan 2021 16:33:19 +0800</pubDate></item><item><title>沙漠之狐Hikma—生于约旦的全球仿制药巨头</title><link>https://mp.weixin.qq.com/s/8hcWQCkbiT7_Ts8dPl7ZaQ</link><description></description><content:encoded><![CDATA[沙漠之狐Hikma—生于约旦的全球仿制药巨头]]></content:encoded><pubDate>Thu, 28 Jan 2021 16:33:19 +0800</pubDate></item><item><title>从香港转战创业板：特色药企康蒂尼</title><link>https://mp.weixin.qq.com/s/a0kejnWhUU_Wm0jl5KmcxQ</link><description></description><content:encoded><![CDATA[从香港转战创业板：特色药企康蒂尼]]></content:encoded><pubDate>Thu, 28 Jan 2021 15:53:30 +0800</pubDate></item><item><title>中国首个氘代新药正式推向市场，价格来了</title><link>https://mp.weixin.qq.com/s/7pMH2KaeRULCH2cvsNqzAw</link><description></description><content:encoded><![CDATA[中国首个氘代新药正式推向市场，价格来了]]></content:encoded><pubDate>Thu, 28 Jan 2021 15:53:30 +0800</pubDate></item><item><title>2020最全回顾:中国新药License out</title><link>https://mp.weixin.qq.com/s/i6bmpkA1HQuIFYb5PO5rCg</link><description></description><content:encoded><![CDATA[2020最全回顾:中国新药License out]]></content:encoded><pubDate>Tue, 26 Jan 2021 09:46:42 +0800</pubDate></item><item><title>《2021年中国制药CDMO产业地图》来袭——梯队排名和分布情况</title><link>https://mp.weixin.qq.com/s/RJJxcxSVgsoDAoZum4Slaw</link><description></description><content:encoded><![CDATA[《2021年中国制药CDMO产业地图》来袭——梯队排名和分布情况]]></content:encoded><pubDate>Tue, 26 Jan 2021 09:46:42 +0800</pubDate></item><item><title>拥有5大技术平台！疫苗新秀苏州起航</title><link>https://mp.weixin.qq.com/s/DkLoDDRrq_AihOk9I3qc9Q</link><description></description><content:encoded><![CDATA[拥有5大技术平台！疫苗新秀苏州起航]]></content:encoded><pubDate>Tue, 26 Jan 2021 09:35:44 +0800</pubDate></item><item><title>来源于西湖大学，这家红细胞药物开发公司完成近亿元融资</title><link>https://mp.weixin.qq.com/s/mdpQ1ZRLD2sCdAvurHiQuA</link><description></description><content:encoded><![CDATA[来源于西湖大学，这家红细胞药物开发公司完成近亿元融资]]></content:encoded><pubDate>Tue, 26 Jan 2021 09:35:44 +0800</pubDate></item><item><title>【官宣】丹诺医药与强生达成抗感染新药合作</title><link>https://mp.weixin.qq.com/s/zE9o6o6vdkGN2sa18TzRzQ</link><description></description><content:encoded><![CDATA[【官宣】丹诺医药与强生达成抗感染新药合作]]></content:encoded><pubDate>Mon, 18 Jan 2021 14:41:46 +0800</pubDate></item><item><title>mRNA赛道热潮：沃森投不进去的艾博生物是什么情况？</title><link>https://mp.weixin.qq.com/s/nTAYtxeXMDYScyz0L65IPA</link><description></description><content:encoded><![CDATA[mRNA赛道热潮：沃森投不进去的艾博生物是什么情况？]]></content:encoded><pubDate>Mon, 18 Jan 2021 14:41:46 +0800</pubDate></item><item><title>国内Biotech Top:1100亿再鼎医药的内部研发管线</title><link>https://mp.weixin.qq.com/s/ZfbhDGq7XdvBJl9-k-7XVg</link><description></description><content:encoded><![CDATA[国内Biotech Top:1100亿再鼎医药的内部研发管线]]></content:encoded><pubDate>Fri, 15 Jan 2021 13:50:11 +0800</pubDate></item><item><title>盟科上市辅导：抗感染新药第一股</title><link>https://mp.weixin.qq.com/s/nsdIx12PVlFwpKTeASCVZg</link><description></description><content:encoded><![CDATA[盟科上市辅导：抗感染新药第一股]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:46:42 +0800</pubDate></item><item><title>特色医药供应商/CDMO：毕得医药辅导上市</title><link>https://mp.weixin.qq.com/s/1j_Z4M7PLxPPnt1RSGKOKQ</link><description></description><content:encoded><![CDATA[特色医药供应商/CDMO：毕得医药辅导上市]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:46:42 +0800</pubDate></item><item><title>Biotech Top：信达生物市值1340亿；全球研发中心落上海</title><link>https://mp.weixin.qq.com/s/AXcgLtHS_IHDdI6JGg01tg</link><description></description><content:encoded><![CDATA[Biotech Top：信达生物市值1340亿；全球研发中心落上海]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:32:26 +0800</pubDate></item><item><title>国内首个CAR-T疗法！复星凯特「益基利仑赛注射液」即将获批上市</title><link>https://mp.weixin.qq.com/s/3zwwQr-f7miG_MjaQHXBng</link><description></description><content:encoded><![CDATA[国内首个CAR-T疗法！复星凯特「益基利仑赛注射液」即将获批上市]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:32:26 +0800</pubDate></item><item><title>益方生物科创板辅导中：KRAS美国已临床启动</title><link>https://mp.weixin.qq.com/s/hw2F4tya4LbCJCr4zriyFA</link><description></description><content:encoded><![CDATA[益方生物科创板辅导中：KRAS美国已临床启动]]></content:encoded><pubDate>Mon, 11 Jan 2021 13:35:22 +0800</pubDate></item><item><title>琅琊榜—2020年CXO公司国际化程度排排坐</title><link>https://mp.weixin.qq.com/s/YASET-PJm2wdKJWMQL6Q7Q</link><description></description><content:encoded><![CDATA[琅琊榜—2020年CXO公司国际化程度排排坐]]></content:encoded><pubDate>Mon, 11 Jan 2021 13:35:22 +0800</pubDate></item></channel></rss>